Glenmark Pharmaceuticals Inc. recalled 22,656 bottles of Theophylline extended-release tablets on August 8, 2025. The recall follows reports of failed dissolution specifications that could impact medication efficacy. Consumers should stop using the product and consult healthcare providers immediately.
Failed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the long-term shelf life stability interval, wherein the dissolution results do not comply with L3 stage dissolution criteria.
Consumers and healthcare providers should stop using this product immediately. Contact Glenmark Pharmaceuticals Inc., USA or your healthcare provider for guidance. Notification method: Letter
The recall affects Theophylline extended-release tablets, 400mg, in 100-count bottles. The products were manufactured by Glenmark Pharmaceuticals Limited in India and distributed nationwide in the USA.
The recall stems from failed dissolution specifications. The dissolution results did not comply with L3 stage criteria, potentially affecting the drug's effectiveness.
No injuries or adverse incidents have been reported associated with this recall. The potential for ineffective medication poses a serious health risk.
Stop using the recalled Theophylline tablets immediately. Contact Glenmark Pharmaceuticals Inc. for further guidance and potential refund options.
Consumers can reach Glenmark Pharmaceuticals Inc. at their website for more information. For additional assistance, consult with healthcare providers.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.